Devonian Health Group is trading 11.36% down at CA$9.75 after opening-day selling from the previous CA$11.00 close, amid recent biotech-sector weakness and a cautious macro backdrop; no specific catalyst has been identified.

  • No credible company-specific announcement dated August 31, 2026 has been identified, and available market coverage lists no company headlines.
  • The previously announced NYSE American listing and offering are earlier developments, not new August 31 news.